These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7680775)

  • 1. Anti-HCV reactivity in dialysis patients: discrepancies between first and second generation tests.
    Beccari M; Sorgato G; Rizzolo L; Veneroni G
    Nephron; 1993; 63(2):238. PubMed ID: 7680775
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus antibody and hepatitis C viremia in pediatric dialysis patients in Taiwan.
    Lin CY; Lin JY; Chen WP
    Nephron; 1993; 65(4):654. PubMed ID: 7508095
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
    Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
    Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis C virus infections in dialysis patients and their contacts using a second generation enzymed-linked immunosorbent assay.
    Schlipköter U; Gladziwa U; Cholmakov K; Weise A; Rasshofer R; Lorbeer B; Luz N; Deinhardt F; Roggendorf M
    Med Microbiol Immunol; 1992; 181(3):173-80. PubMed ID: 1381808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-HCV-screening of blood donors in Gothenburg--the second generation tests are more specific].
    Lindholm A; Shev S; Norkrans G; Iwarson S; Hermodsson S
    Lakartidningen; 1991 Oct; 88(42):3475-6. PubMed ID: 1658502
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of non-A non-B hepatitis and anti-HCV antibodies in a Portuguese dialysis population.
    Carrera F; Silva JG; Pires C; Oliveira C
    Nephrol Dial Transplant; 1992; 7(9):913-6. PubMed ID: 1383874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus antibodies in dialysis pediatric patients.
    Di Loreto M; Ferrante M; Panaro A; Sorino P; Collela V; Caringella DA
    Nephron; 1992; 61(3):365-6. PubMed ID: 1323793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
    Kallinowski B; Theilmann L; Gmelin K; Andrassy K; Deppermann D; Weinel B; Kommerell B
    Nephron; 1991; 59(2):236-8. PubMed ID: 1659672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
    Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
    Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of hepatitis C virus antibodies in hemodialysis patients.
    Machida J; Yamaguchi K; Ueda S; Yoshida M; Kusumoto Y; Nishimura Y; Futami G; Ishii T; Watanabe T; Takatsuki K
    Nephron; 1992; 60(1):117-8. PubMed ID: 1310800
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus antibodies in patients on hemodialysis.
    San Miguel G; Crespo J; Echevarria S; D'Francisco A; Gomez Ullate P; Pons Romero F
    Infect Control Hosp Epidemiol; 1992 May; 13(5):254, 256. PubMed ID: 1375612
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between first and second generation tests to determine the frequency of anti-HCV antibodies in uremic patients in replacement dialytic therapy.
    Mazzotta L; Landucci G; Pfanner L; Carlini A; Angelini D; Giusti R; Antonelli A
    Nephron; 1992; 61(3):354-5. PubMed ID: 1323789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved detection of hepatitis C virus antibodies in high-risk populations.
    McHutchison JG; Person JL; Govindarajan S; Valinluck B; Gore T; Lee SR; Nelles M; Polito A; Chien D; DiNello R
    Hepatology; 1992 Jan; 15(1):19-25. PubMed ID: 1309365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.
    Chan TM; Lok AS; Cheng IK
    Nephrol Dial Transplant; 1991; 6(12):944-7. PubMed ID: 1724691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Occurrence of antibodies against hepatitis C virus (anti-HCV) in patients on long-term hemodialysis].
    Sułowicz W; Dolezal M; Hejmo D; Gerhardt E; Ignacak E
    Przegl Lek; 1992; 49(1-2):67-8. PubMed ID: 1333622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors.
    Malaguti M; Capece R; Marciano M; Arena G; Luciani MP; Striano M; Biagini M
    Nephron; 1992; 61(3):346. PubMed ID: 1323786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liatek HCV: the six-antigen test for confirmation of the presence of anti-HCV antibodies].
    Juszczyk J; Flieger J; Migdalski P; Skalisz H
    Przegl Epidemiol; 1992; 46(1-2):11-7. PubMed ID: 1282266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of anti-HCV among haemodialysis patients in Turkey: a multicentre study.
    Akpolat T; Arik N; Günaydin M; Utaş C; Dilek K; Caglar S; Candan F; Süleymanlar G; Paydaş S; Sen S
    Nephrol Dial Transplant; 1995; 10(4):479-80. PubMed ID: 7542753
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group.
    Jadoul M; Cornu C; van Ypersele de Strihou C
    Kidney Int; 1993 Dec; 44(6):1322-6. PubMed ID: 7508005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.